Associate Principal Investigators and the HEAL-COVID trial: good for trainees, good for trials.

ABSTRACT:

Background

The NIHR's Associate Principal Investigator (API) Scheme in the United Kingdom was expanded nationally in 2020 with the aim of training clinicians to become Principal Investigators for clinical research in the future. The HEAL-COVID adaptive platform trial is an urgent public health study registered with the API Scheme. Within eighteen months of opening, the trial had recruited almost 1200 patients with over 100 active sites. Here we describe our experiences of APIs working on the trial with two broad objectives. Firstly, we aim to explore through qualitative methods the impact that the scheme has had on the APIs' professional development. Secondly, we aim to quantify the impact that the APIs have had on the recruitment of patients into the trial.

Methods

The prof

SUBMITTER: Newman J 

PROVIDER: S-EPMC10821510 | biostudies-literature | 2024 Jan

REPOSITORIES: biostudies-literature